Chest / Cardiac for Tuesday, April 8th, 2025

Contributed by
Severance Hospital
Mi-Jung Lee, Haesung Yoon, and Hyun Joo Shin.
History
18-year-old girl with night fever and mild headache.
Underlying Crohn's disease, on infliximab.
Images (Click any image to enlarge)
Question
What is the most likely diagnosis?
Your answer
Please log in to see your results.
Correct answer
Miliary tuberculosis following infliximab therapy for Crohn disease
Discussion
Infliximab (TNF-α antagonist)
- Chimeric immunoglobulin G (IgG) monoclonal antibody targeting TNF-a.
- Effective treatment for steroid dependant, fistulizing Crohn's disease.
- Risk of disseminations of intracellular pathogens normally controlled by the cell mediated granulomatous inflammatory process and potential reactivation of Tuberculosis.
According to the report by Keane et al (N Engl J Med 2001;345:1098-104).
- Until 2001, 70 reported cases of TB among the approximately 147,000 ,000 treated patients, a frequency much higher than the reported frequency of other opportunistic infections.
- Received treatment for a median of 12 weeks.
- In 48 patients, TB developed after 3 or fewer infusions.
- Extrapulmonary disease occurred in 40 patients (17 with disseminated disease)
- 64/70 were from countries with low incidence of TB
References
- Keane et al, N Engl J Med 2001;345:1098-104.